Stockreport

Convergent Therapeutics Announces First Shipments of Actinium 225 from Cardinal Health to Support the CONVERGE-01 Phase 2 Clinical Trial [Yahoo! Finance]

Cardinal Health, Inc.  (CAH) 
Last cardinal health, inc. earnings: 2/6 06:55 am Check Earnings Report
US:NYSE Investor Relations: ir.cardinalhealth.com/home
PDF generation radiopharmaceutical therapies for the treatment of prostate cancer and other cancers, today announced the receipt of the first shipments of non-carrier added [Read more]